Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SPPI
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Spectrum Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology & Medical Research
- Market cap
- 211.40M
- Ent value
- 239.90M
- Price/Sales
- 8.20
- Price/Book
- 7.89
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- 14.71
- PEG
- -
- EPS growth
- -16.85%
- 1 year return
- 17.05%
- 3 year return
- -31.18%
- 5 year return
- -45.27%
- 10 year return
- -18.97%
Last updated: 2024-12-17
DIVIDENDS
SPPI does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 8.20 |
| Price to Book | 7.89 |
| EV to Sales | 9.31 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 205.25M |
| EPS (TTM) | -0.32 |
| FCF per share (TTM) | -0.44 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 25.77M |
| Gross profit (TTM) | 22.87M |
| Operating income (TTM) | -63.51M |
| Net income (TTM) | -65.06M |
| EPS (TTM) | -0.32 |
| EPS (1y forward) | 0.07 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 88.75% |
| Operating margin (TTM) | -246.45% |
| Profit margin (TTM) | -252.47% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 52.37M |
| Net receivables | 33.64M |
| Total current assets | 105.38M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 107.67M |
| Accounts payable | 35.38M |
| Short/Current long term debt | 29.61M |
| Total current liabilities | 38.88M |
| Total liabilities | 80.87M |
| Shareholder's equity | 26.80M |
| Net tangible assets | 26.80M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -88.13M |
| Capital expenditures (TTM) | 342.00K |
| Free cash flow (TTM) | -88.47M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -242.70% |
| Return on Assets | -60.42% |
| Return on Invested Capital | -115.31% |
| Cash Return on Invested Capital | -156.83% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| SPPI | S&P500 | |
| Current price drop from All-time high | -99.83% | -6.47% |
| Highest price drop | -99.95% | -56.47% |
| Date of highest drop | 28 Dec 2022 | 9 Mar 2009 |
| Avg drop from high | -88.77% | -10.99% |
| Avg time to new high | 282 days | 12 days |
| Max time to new high | 5891 days | 1805 days |
COMPANY DETAILS
Marketcap
211.40M
Marketcap category
Small-cap
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products. It offers ROLVEDON(Eflapegrastim), a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. The company develops Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and license agreement with Therapyx, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Boston, Massachusetts. As of July 31, 2023, Spectrum Pharmaceuticals, Inc. operates as a subsidiary of Assertio Holdings, Inc.
Employees
86
Website
Investor relations
-
SEC filings
CEO
Joseph W. Turgeon
Country
USA
City
Henderson
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner